Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

406 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Myeloperoxidase and cardiovascular disease.
Nicholls SJ, Hazen SL. Nicholls SJ, et al. Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1102-11. doi: 10.1161/01.ATV.0000163262.83456.6d. Epub 2005 Mar 24. Arterioscler Thromb Vasc Biol. 2005. PMID: 15790935 Review.
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Nissen SE, et al. JAMA. 2006 Apr 5;295(13):1556-65. doi: 10.1001/jama.295.13.jpc60002. Epub 2006 Mar 13. JAMA. 2006. PMID: 16533939 Clinical Trial.
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM; ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators. Nissen SE, et al. N Engl J Med. 2006 Mar 23;354(12):1253-63. doi: 10.1056/NEJMoa054699. N Engl J Med. 2006. PMID: 16554527 Clinical Trial.
Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.
Nicholls SJ, Tuzcu EM, Crowe T, Sipahi I, Schoenhagen P, Kapadia S, Hazen SL, Wun CC, Norton M, Ntanios F, Nissen SE. Nicholls SJ, et al. J Am Coll Cardiol. 2006 May 16;47(10):1967-75. doi: 10.1016/j.jacc.2005.12.058. Epub 2006 Apr 24. J Am Coll Cardiol. 2006. PMID: 16697312
Application of intravascular ultrasound in anti-atherosclerotic drug development.
Nicholls SJ, Sipahi I, Schoenhagen P, Crowe T, Tuzcu EM, Nissen SE. Nicholls SJ, et al. Nat Rev Drug Discov. 2006 Jun;5(6):485-92. doi: 10.1038/nrd2040. Epub 2006 May 12. Nat Rev Drug Discov. 2006. PMID: 16699493 Review.
Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study).
Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Hazen SL, Ntanios F, Wun CC, Nissen SE. Nicholls SJ, et al. Am J Cardiol. 2006 Jun 1;97(11):1553-7. doi: 10.1016/j.amjcard.2005.12.042. Epub 2006 Apr 6. Am J Cardiol. 2006. PMID: 16728212 Clinical Trial.
Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE. Schoenhagen P, et al. Circulation. 2006 Jun 20;113(24):2826-34. doi: 10.1161/CIRCULATIONAHA.105.585703. Epub 2006 Jun 12. Circulation. 2006. PMID: 16769916 Clinical Trial.
Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.
Nicholls SJ, Sipahi I, Schoenhagen P, Wisniewski L, Churchill T, Crowe T, Goormastic M, Wolski K, Tuzcu EM, Nissen SE; ACTIVATE Investigators. Nicholls SJ, et al. Am Heart J. 2006 Jul;152(1):67-74. doi: 10.1016/j.ahj.2005.10.025. Am Heart J. 2006. PMID: 16824833
Intravascular ultrasound in cardiovascular medicine.
Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Nissen SE. Nicholls SJ, et al. Circulation. 2006 Jul 25;114(4):e55-9. doi: 10.1161/CIRCULATIONAHA.106.637942. Circulation. 2006. PMID: 16864731 Review. No abstract available.
406 results
Jump to page
Feedback